Leopard syndrome, hypertrophic cardiomyopathy, sudden death
Introduction
Cardiomyopathy lentiginosis is known as Leopard syndrome, which is a mnemonic rule for multiple Lentigines injuries, Electrocardiographic conduction abnormalities, Ocular hypertelorism, Pulmonary stenosis, genital and reproductive Abnormalities, Retarded growth and Deafness
.
Patients have lentigines injuries over the body, which are a typical symptom of this disease. They may also present with other symptoms, such as ocular hypertelorism, low-set ears, retarded growth and delay of formation of secondary sexual characters 2 
There are cardiac abnormalities such as: prolongation of PR interval; bundle-branch blocks, complete atrioventricular block and asymmetrical hypertrophy of left ventricle. This last problem mainly affects the anterior wall and interventricular septum, which characterizes hypertrophic cardiomyopathy (HCM) 3 . This is the first report of Leopard syndrome related to HCM in Brazil, in which we discuss the form of stratification and prevention of sudden cardiac death.
Case Report
A 27-year-old patient came for a sudden death risk consultation and assessment and reported a history of a cousin who had sudden death when he was 23 years old.
She complained about dyspnea during more-than-ordinary activities (New York Heart Association [NYHA] functional class II) and short-term tachycardia. She did not complain about syncope or chest pain.
She has Von Willebrand disease, which was diagnosed when she was 13 years old. When she was 23 years old, she was admitted to the hospital for an intravenous antibiotic treatment due to an infective endocarditis in the mitral valve. This infection occurred after a dental treatment.
On physical examination, she had multiple lentigines on the neck and torso (figure 1), ocular hypertelorism, exotropic strabismus and retardation of growth. Cardiac auscultation revealed a harsh murmur along the left sternal border (3+/6), which was intensified by Valsalva maneuver. It also revealed a mild murmur in the mitral area (2+/6), radiating to the axilla. 24-hour holter showed ten episodes of non-sustained ventricular tachycardia (NSVT) and heart rate above 120 bpm. Magnetic resonance imaging (MRI) of the heart showed a diffuse myocardial fibrosis on inferior wall and septum of left ventricle. The patient was using atenolol 200 mg/day and losartan 100 mg/day. Although losartan had been proscribed in HCM treatment, especially in obstructive form, it was retained because the patient reported an improvement in dyspnea.
Discussion
A 27-year-old patient complains about dyspnea during more-than-ordinary activities and has HCM associated with Leopard syndrome.
HCM estimated prevalence is approximately 1:500 individuals (0.2%) aged 25 to 35 years. It is a genetic disease with dominant autosomal inheritance, which is caused by abnormalities in ten chromosomes and more than 400 mutations in genes encoding sarcomeric proteins 4 . Sudden cardiac death (SCD) is the most feared complication and occurs mainly in young and asymptomatic individuals. It can also reach an incidence of 30% when multiple risk factors are present A possible explanation of pathogenesis of this syndrome is an abnormality in neural crest cells -from which autonomic e45 ganglia cells and Schwann cells of peripheral nerves originate -and an abnormality in nerve endings of the parasympathetic nervous system in heart ventricles. These cells can also increase melanocytes and could explain the association with lentiginosis. A genetic defect related to the syndrome development has been located on chromosome 12 (12q24.1). Mutations on this gene may cause other genetic diseases with heart malformations, such as Noonan syndrome, lentigines cardiomyopathy and Leopard syndrome 7 .
Regarding our patient, who was little symptomatic and has important hypertrophic cardiomyopathy, the key-point is to stratify sudden death risk and determine the best treatment option. . There is a 5% risk for SCD per annum if patients have two or more risk factors, and there is only 1% when none of these factors is found 5 .
Other factors should also be considered in patient assessment: age when disease was diagnosed; left ventricular outflow tract gradient > 30 mmHg; mainly genetic malignant mutations (troponin T gene and beta-myosin heavy chain) 8 . If MRI of heart shows late enhancement and fibrosis areas, it has prognostic value. Diffuse fibrosis distribution was related to worse SCD prognosis and left ventricle hypertrophy 9 .
Previous studies failed to show the benefit of antiarrhythmic drugs, which were used for sudden death prevention. Amiodarone can eliminate complex ventricular arrhythmias, but it does not protect against SCD. It would be used only in patients in whom ICD implantation is not feasible and in patients with SCD risk factors or even history of non-sustained ventricular tachycardia (VT) or ventricular fibrillation (FV) 8, 10 .
Regarding high-risk patients who have two or more risk factors, ICD implantation is recommended for primary SCD prevention, with a 5% annual incidence of appropriate shocks 7 .
Our patient has a rare syndrome related to HMC and has a high sudden death risk due to: family history of sudden death; myocardial hypertrophy > 30 mm; NSVT on holter; and myocardial fibrosis which was observed in MRI. In this case, ICD implantation was recommended for primary prevention.
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